Regeneron Pharmaceuticals Inc banner

Regeneron Pharmaceuticals Inc
NASDAQ:REGN

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Watchlist
Price: 748.87 USD -2.47% Market Closed
Market Cap: $79.2B

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Regeneron Pharmaceuticals Inc

Margins Comparison
Regeneron Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
887.6B USD
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.5B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
189.2B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
110.8B USD
Loading...
Loading...
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
367.6B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.5B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Regeneron Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
887.6B USD
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
189.2B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
110.8B USD
Loading...
Loading...
Loading...
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
367.6B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.5B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Regeneron Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett